Patient-reported outcome measurement in community-acquired pneumonia: feasibility of routine application in an elderly hospitalized population
- Author(s)
- Lloyd, MA; Tang, CY; Callander, EJ; Janus, ED; Karahalios, A; Skinner, EH; Lowe, S; Karunajeewa, HA;
- Journal Title
- Pilot and Feasibility Studies
- Publication Type
- Journal Article
- Abstract
- Background: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide, but few studies have evaluated the feasibility of routine patient-reported outcome measures (PROMs) in this illness. This study investigates the feasibility and limitations of three credible PROM instruments in a representative hospitalized cohort to identify potential barriers to routine application. Methods: A sample of multimorbid hospitalized subjects meeting a standardized CAP definition was recruited. Demographic and clinical data of those able and unable to participate in PROM assessment were compared. The EQ-5D-5L, CAP-Sym 18 Questionnaire, and Late-Life Function and Disability Instrument (LLFDI) were administered (via face-to-face interview) at admission and discharge and (via phone interview or mail) at 30 and 90 days post-discharge. Feasibility measures included the proportion of individuals able to participate in assessment, attrition rates, data completeness, and instrument completion times. Scores at admission and 30 days post-discharge were examined for association with age. Results: Of 82 subjects screened, 44 (54%) participated. Cognitive impairment (n = 12, 15%) commonly precluded participation. Seventeen (39%) participants were lost to follow-up by 90 days. Missing data at item level was negligible for all instruments, regardless of the mode of completion. Completion of the three instruments collectively in a face-to-face interview took a median of 17 min (IQ range 13-21) per participant. The burden of reported symptoms at admission was higher for younger participants aged 18-74 years (mean (standard deviation)) CAP-Sym 18 score at admission 34.2 (18.6) vs. 19.0 (11.3) for those aged >/= 75 years. Conclusions: Routine application of PROMs can provide valuable information relating to multiple aspects of clinical recovery for individuals hospitalized with CAP. However, heterogeneous demographic characteristics and complex underlying health status introduce challenges to feasibility and interpretability of these instruments in this population. Trial registration: ClinicalTrials.gov, NCT02835040.
- Publisher
- BMC
- Research Division(s)
- Population Health And Immunity
- PubMed ID
- 31372236
- Publisher's Version
- https://doi.org/10.1186/s40814-019-0481-y
- Open Access at Publisher's Site
https://doi.org/10.1186/s40814-019-0481-y- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2019-08-13 12:35:12
Last Modified: 2019-08-13 01:03:38